Health Care Select Sector SPDR® ETF (XLV)

Add to Watchlists
Create an Alert
83.14 +0.98  +1.19% NYSE Arca Apr 26, 13:36 Delayed 2m USD
View Full Chart
XLV Price Chart

XLV Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 3.13% 3.10% 0.61% 20
3M -7.99% -8.00% -6.66% 53
6M -0.26% -0.29% 2.39% 76
YTD -0.28% -0.19% 1.22% 67
1Y 11.61% 11.57% 13.88% 54
3Y 4.96% 4.96% 2.01% 23
5Y 13.26% 13.26% 13.79% 49
10Y 11.91% 11.91% 12.96% 66
As of April 25, 2018. Returns for periods of 1 year and above are annualized.

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.17% 0.17% 0.00%
Stock 99.83% 99.83% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 24, 2018

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of April 24, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.41%
Industrials 0.00%
Real Estate 0.00%
Technology 0.59%
Utilities 0.00%
As of April 24, 2018

XLV Stock Market Capitalization

Giant 56.74%
Large 38.27%
Medium 4.99%
Small 0.00%
Micro 0.00%
As of April 24, 2018

XLV Stock Style Exposure

Large Cap Value 38.04%
Large Cap Blend 25.86%
Large Cap Growth 31.11%
Mid Cap Value 0.82%
Mid Cap Blend 2.57%
Mid Cap Growth 1.60%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of April 24, 2018
View More Holdings

XLV Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 10.90% 128.90 +1.69%
UNH UnitedHealth Group Inc 7.30% 237.26 +1.00%
PFE Pfizer Inc 7.10% 37.05 +1.01%
MRK Merck & Co Inc 5.22% 59.57 -0.10%
ABBV AbbVie Inc 4.69% 96.33 +4.85%
AMGN Amgen Inc 3.70% 174.95 +0.07%
MDT Medtronic PLC 3.46% 80.28 +1.03%
ABT Abbott Laboratories 3.26% 59.22 +0.97%
GILD Gilead Sciences Inc 3.07% 73.04 -0.29%
TMO Thermo Fisher Scientific Inc 2.76% 214.58 +0.05%
As of April 24, 2018
Advertisement

XLV One Page Reports

XLV Basic Info

Style
Equity Style Large Cap/Blend
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD
100.0%

XLV Manager Info

Name Tenure
Dwayne Hancock 1.08 yrs
Karl Schneider 3.01 yrs
Michael Feehily 7.01 yrs

XLV Net Fund Flows

1M 85.59M
3M -1.053B
6M -2.419B
YTD -1.053B
1Y -2.108B
3Y -498.56M
5Y 2.283B
10Y 5.356B
As of March 31, 2018

XLV Risk Info

Beta (5Y) 0.9066
Max Drawdown (All) 39.17%
Historical Sharpe (10Y) 0.8931
Historical Sortino (All) 0.70
30-Day Rolling Volatility 19.78%
Daily Value at Risk (VaR) 1% (All) 3.04%
Monthly Value at Risk (VaR) 1% (All) 13.21%

XLV Fundamentals

Dividend Yield TTM (4-26-18) 1.49%
SEC Yield (4-24-18) 1.53%
Weighted Average PE Ratio 25.93
Weighted Average Price to Sales Ratio 1.807
Weighted Average Price to Book Ratio 3.844
Weighted Median ROE 17.33%
Weighted Median ROA 5.30%
Forecasted Dividend Yield 1.79%
Forecasted PE Ratio 15.30
Forecasted Price to Sales Ratio 1.690
Forecasted Price to Book Ratio 3.451
Number of Holdings 62
As of April 24, 2018

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 10.74%
Forecasted Book Value Growth 7.05%
Forecasted Cash Flow Growth 7.39%
Forecasted Earnings Growth -0.11%
Forecasted Revenue Growth 8.15%
As of April 24, 2018

XLV Comparables

Edit

XLV Attributes

Key Dates
Inception Date 12/16/1998
Termination Date
Last Annual Report Date 9/30/2017
Last Prospectus Date 1/31/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XLV Excel Add-In Codes

  • Name: =YCI("XLV","name")
  • Broad Asset Class: =YCI("XLV", "broad_asset_class")
  • Broad Category: =YCI("XLV", "broad_category_group")
  • Prospectus Objective: =YCI("XLV", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.